Enlivex Therapeutics

ENLV

Enlivex Therapeutics has been a target of short sellers for a while. The current short interest of 10.40% is significantly below the average of the last 12 months (27.01%).

Short Interest Trend

Share Price

Total NSP

10.40%

+3.96%

vs. last month

Also interesting? All insider buys at Enlivex Therapeutics

Note: The short selling data for Enlivex Therapeutics may be distorted by a recent stock split!

Found an error? Questions? Ideas?